Anna Eshoo: “Your leadership on substance use disorder is unparalleled.”

I want to ask you if you will consider STAs and if you will commit to providing the public transparency that is really due because this is a huge issue?

You did a great job, and I think that you answered--with your answers you were highly instructive to all of the members of the committee.

the words that we write walk into people's lives.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.